0861 A Phase 2a, Double-blind, Placebo-controlled Study of ORX750 in Patients with Narcolepsy (type 1 and 2) and Idiopathic Hypersomnia: Study Design

Yves Dauvilliers; Guiseppe Plazzi; David Plante; Emmanuel Mignot; Thomas Roth; Amanda Sterkel; Deborah Hartman; Jennifer Kong; Mario Accardi; Saurabh Saha; Ellie Im

doi:10.1093/sleep/zsaf090.0861

Retour

0861 A Phase 2a, Double-blind, Placebo-controlled Study of ORX750 in Patients with Narcolepsy (type 1 and 2) and Idiopathic Hypersomnia: Study Design

Article de revue

Avec comité de lecture

0861 A Phase 2a, Double-blind, Placebo-controlled Study of ORX750 in Patients with Narcolepsy (type 1 and 2) and Idiopathic Hypersomnia: Study Design

Yves Dauvilliers, Guiseppe Plazzi, David Plante, Emmanuel Mignot, Thomas Roth, Amanda Sterkel, Deborah Hartman, Jennifer Kong, Mario Accardi, Saurabh Saha, …

Sleep (New York, N.Y.), Vol.48(Supplement_1), pp.A373-A374

19/05/2025

DOI: https://doi.org/10.1093/sleep/zsaf090.0861

Indicateurs

1 Consultations de la notice

Détails

Titre: 0861 A Phase 2a, Double-blind, Placebo-controlled Study of ORX750 in Patients with Narcolepsy (type 1 and 2) and Idiopathic Hypersomnia: Study Design
Créateurs - sans rôle: Yves Dauvilliers
Guiseppe Plazzi
David Plante
Emmanuel Mignot
Thomas Roth
Amanda Sterkel
Deborah Hartman
Jennifer Kong
Mario Accardi
Saurabh Saha
Ellie Im
Détails de publication: Sleep (New York, N.Y.), Vol.48(Supplement_1), pp.A373-A374
Identifiants: 99139941009311
Unité académique: Institut des Neurosciences de Montpellier - INM
Langue: English
Type de ressource: Journal article